ESiORin henkilöstön julkaisuja

Cost-effectiveness, value of information and budget impact of certolizumab pegol compared to subcutaneous tumor necrosis factor (TNF) inhibitors and methotrexate in the treatment of moderate-to-severe rheumatoid arthritis in Finland

Soini E, Hallinen T, et al. Cost-effectiveness, value of information and budget impact of certolizumab pegol compared to subcutaneous tumor necrosis factor (TNF) inhibitors and methotrexate in the treatment of moderate-to-severe rheumatoid arthritis in Finland. Value Health 2010;13(7):A243. Podium at the Annual ISPOR European Congress.

Scientific conference reference

Abstract

Hallinen T, Soini E

The economic impact of weight loss for patients with newly diagnosed type 2 diabetes mellitus (T2DM) in the US

Willis M, Asseburg C, et al. The economic impact of weight loss for patients with newly diagnosed type 2 diabetes mellitus (T2DM) in the US. Value in Health 2010;13(3):A59.

Scientific conference reference

Abstract

Asseburg C

Economic evaluation of lacosamide in the treatment of partial-onset epilepsy in Finland: Cost-effectiveness and budget impact modelling

Soini E, Martikainen J, et al. Economic evaluation of lacosamide in the treatment of partial-onset epilepsy in Finland: Cost-effectiveness and budget impact modelling. ECHE 2010.

Scientific conference reference

Martikainen J, Soini E

Comprehensive health economic assessment of sequenced treatment with biologics in moderate-to-severe rheumatoid arthritis: Analysis based on ACR50 and ACR70 responses

Soini E, Hallinen T, et al. Comprehensive health economic assessment of sequenced treatment with biologics in moderate-to-severe rheumatoid arthritis: Analysis based on ACR50 and ACR70 responses. Arthritis & Rheumatology 2010;62 Suppl 10:759. Poster at the Annual Scientific Meeting of American College of Rheumatology (ACR/ARHP 2010). ACR Notable Poster Nomination.

Scientific conference reference

On request

Hallinen T, Soini E

Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden – with model applications for Denmark, Norway and Finland

Hjalte F, Asseburg C, et al. Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden – with model applications for Denmark, Norway and Finland. J Eur Acad Dermatol Venereol 2010;24(4):474-80.

Scientific publication

Abstract, Full text on Request

Asseburg C

Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project

Wailoo AJ, Goodacre S, Sampson F, Hernández Alava M, Asseburg C, et al. Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty Project. Heart 2010;96(9):668-72.

Scientific publication

Abstract, Full text on Request

Asseburg C

Millainen on hyvä lääkkeen hoidollisen ja taloudellisen arvon arviointi?

Not available online

Martikainen J, Nyblin K. Millainen on hyvä lääkkeen hoidollisen ja taloudellisen arvon arviointi? Dosis 2010;26:33-42.

Scientific publication

Full text on Request

Martikainen J

The functional response of a generalist predator

Smout S, Asseburg C, et al. The functional response of a generalist predator. PLoS One 2010;5(5):e10761

Scientific publication

Open Access

Asseburg C

Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden

Martikainen J, Soini E, et al. Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden. Curr Med Res Opin 2010;26(2):389-96.

Scientific publication

Abstract, Full text on Request

Martikainen J, Soini E

Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland

Soini E, Davies G, Martikainen J, et al. Population-based health-economic evaluation of the secondary prevention of coronary heart disease in Finland. Curr Med Res Opin 2010;26(1):25-36.

Scientific publication

Abstract, Full text on Request

Martikainen J, Soini E

Taloudellisen arvioinnin asema terveydenhuollon menetelmien käyttöönotossa. Esimerkkinä kansallinen rokotusohjelma

Laine J, Soini E, Martikainen J. Taloudellisen arvioinnin asema terveydenhuollon menetelmien käyttöönotossa. Esimerkkinä kansallinen rokotusohjelma. Suom Lääkäril 2010;65(11):1019-24.

Scientific publication

PDF

Martikainen J, Soini E

Toiveena taloudellisen arvioinnin lisääntyvä hyödyntäminen

Laine J, Soini E, Martikainen J. Toiveena taloudellisen arvioinnin lisääntyvä hyödyntäminen. Suom Lääkäril 2010;65(11):1025-6.

Other publication

PDF

Martikainen J, Soini E

Budget impact analysis of trastuzumab in early breast cancer: a hospital district perspective

Purmonen TT, Auvinen PK, Martikainen JA. Budget impact analysis of trastuzumab in early breast cancer: a hospital district perspective. Int J Technol Assess Health Care 2010;26(2):163-9.

Scientific publication

Abstract, Full text on Request

Martikainen J

Risk factors for persistent frequent use of the primary health care services among frequent attenders: a Bayesian approach

Koskela T, Ryynanen OP, Soini E. Risk factors for persistent frequent use of the primary health care services among frequent attenders: a Bayesian approach. Scand J Prim Health Care 2010;28(1):55-61.

Scientific publication

Open Access

Soini E

The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea

Sahlman J, et al. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 2010;19(2):341-8. Collaborators: Soini E, Martikainen J.

Scientific publication

Open Access

Martikainen J, Soini E

Cost-utility of different treatment strategies after the failure of tumor necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting

Hallinen T, Soini E, et al. Cost-utility of different treatment strategies after the failure of tumor necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting. Rheumatology (Oxford) 2010;49(4):767-77.

Scientific publication

Open Access

Hallinen T, Soini E

Terveystaloudellinen arviointi tutkimusten yhteydessä

Soini E. Terveystaloudellinen arviointi tutkimusten yhteydessä. Lääketietokeskus: Työkaluja lääkkeiden taloudelliseen arviointiin. Helsinki: training. Nov 25, 2009.

Other publication

On request

Soini E

Astman hoito – kuluja vai säästöjä?

Soini E. Astman hoito – kuluja vai säästöjä? Helsingin Aluelääkäriyhdistyksen syyskokous. Sep 25, 2009.

Other publication

On request

Soini E

Kustannus-vaikuttavuustieto: miten sitä voidaan hyödyntää ja miten sitä on hyödynnetty lääketeollisuudessa, sairaaloissa ja elintarvikealan yrityksissä

Soini E. Kustannus-vaikuttavuustieto: miten sitä voidaan hyödyntää ja miten sitä on hyödynnetty lääketeollisuudessa, sairaaloissa ja elintarvikealan yrityksissä. KWRC Seminar. May 8, 2009.

Other publication

On request

Soini E

Lääkehoitojen terveystaloudellinen arviointi. Harvinaiset sairaudet ja harvinaissairauslääkkeet kansallisella tasolla

Soini E. Lääkehoitojen terveystaloudellinen arviointi. Harvinaiset sairaudet ja harvinaissairauslääkkeet kansallisella tasolla. Harvinaiset Sairaudet -päivä. Oct 9, 2009. DVD.

Other publication

On request

Soini E

Harvinaissairauslääkkeistä ja niiden taloudellisesta arvioinnista

Soini E. Harvinaissairauslääkkeistä ja niiden taloudellisesta arvioinnista. Mediuutiset. Mar 30, 2009.

Other publication

On request

Soini E

Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up

Tuomilehto H, et al. Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr 2010;92(4):688-96. Collaborators: Soini E, Martikainen J.

Scientific publication

Open Access

Martikainen J, Soini E

Validation of the IHE/J&J economic simulation model of type-2 diabetes mellitus (T2DM)

Asseburg C, et al. Validation of the IHE/J&J economic simulation model of type-2 diabetes mellitus (T2DM). Value in Health 2009;12:A26.

Scientific conference reference

Abstract

Asseburg C

Lääkehoitojen terveystaloudellinen arviointi

Not available online

Soini E. Lääkehoitojen terveystaloudellinen arviointi. Harvinaiset Sairaudet -päivä. Oct 9, 2009. Podium.

Scientific conference reference

On request

Soini E

Perusterveydenhuollon vastaanottotoiminnan eri tuottamismallien kustannus-vaikuttavuusanalyysi

Not available online

Koskela T, Ryynanen OP, Soini E. Perusterveydenhuollon vastaanottotoiminnan eri tuottamismallien kustannus-vaikuttavuusanalyysi. SYLY Päivät 2009 Yleislääketieteen päivät. Oct 8-9, 2009. Tieteestä toiminnaksi. Podium.

Scientific conference reference

On request

Soini E

Risk factors for Persistent Use of the Primary Health Care Services: A Bayesian approach

Koskela T, Ryynänen O, Soini E. Risk factors for Persistent Use of the Primary Health Care Services: A Bayesian approach. 15th Wonca Europe Congress. Sep 16-19, 2009. Article published in Scand J Prim Health Care 2010;28(1):55-61.

Scientific conference reference

Soini E

Cost-effectiveness and budget impact modelling of lacosamide in the treatment of partial-onset epilepsy in Finland

Not available online

Soini E, Martikainen J, et al. Cost-effectiveness and budget impact modelling of lacosamide in the treatment of partial-onset epilepsy in Finland. IV Neurologiapäivät Neuroscience Finland 2009; P-11.

Scientific conference reference

On request

Martikainen J, Soini E

Cost-effectiveness of oral triptan therapy in Finland

Not available online

Purmonen T, Peura P, Turunen J, Martikainen J. Cost-effectiveness of oral triptan therapy in Finland. 4th Nordic Social Pharmacy and Health Services Research Conference. Jun 15-16, 2009, 13.

Scientific conference reference

On request

Martikainen J

Cost-effectiveness and budget impact modelling of lacosamide in the treatment of partial-onset seizures in Finland

Soini E, Martikainen J, et al. Cost-effectiveness and budget impact modelling of lacosamide in the treatment of partial-onset seizures in Finland. Value in Health 2009;12(7):A367.

Scientific conference reference

Abstract

Martikainen J, Soini E

Cost-utility of agomelatine, venlafaxine and placebo in the treatment of major depressive disorder (MDD) in Finland – Economic modelling study using representative population data

Soini E, Hallinen T. Cost-utility of agomelatine, venlafaxine and placebo in the treatment of major depressive disorder (MDD) in Finland – Economic modelling study using representative population data. Award finalist. Value in Health 2009;12(7):A359.

Scientific conference reference

Abstract

Hallinen T, Soini E